TY  - GEN
AU  - Hedrington,Maka S
AU  - Tsiskarishvili,Ana
AU  - Davis,Stephen N
TI  - Subcutaneous semaglutide (NN9535) for the treatment of type 2 diabetes
SN  - 1744-7682
PY  - 2018///1119
KW  - Blood Glucose
KW  - analysis
KW  - Body Weight
KW  - Clinical Trials as Topic
KW  - Diabetes Mellitus, Type 2
KW  - drug therapy
KW  - Glucagon-Like Peptide-1 Receptor
KW  - metabolism
KW  - Glucagon-Like Peptides
KW  - chemistry
KW  - Glycated Hemoglobin
KW  - Humans
KW  - Hypoglycemic Agents
KW  - Injections, Subcutaneous
KW  - Glucagon-Like Peptide-1 Receptor Agonists
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1080/14712598.2018.1439014
ER  -